IA
ANIX icon

IFP Advisors’s Anixa Biosciences ANIX Stock Holding History

IFP Advisors’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.25K Buy
1,160
+500
+76% +$1.39K ﹤0.01% 4020
2026
Q1 		$1.7K Buy
660
+160
+32% +$474 ﹤0.01% 4017
2025
Q4 		$1.56K Hold
500
– – ﹤0.01% 3925
2025
Q3 		$1.65K Hold
500
– – ﹤0.01% 3773
2025
Q2 		$1.65K Hold
500
– – ﹤0.01% 3991
2025
Q1 		$1.43K Buy
+500
New +$1.43K ﹤0.01% 3250
2017
Q4 		– Sell
-1,000
Closed -$3K – 3796
2017
Q3 		$3K Hold
1,000
– – ﹤0.01% 3585
2017
Q2 		$1K Buy
+1,000
New +$1.39K ﹤0.01% 3846

Other funds holding ANIX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $5.21B AUM 31.48% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

IFP Advisors's ANIX Position: Q2 2026 in Review

IFP Advisors increased its Anixa Biosciences (ANIX) stake by 76% in Q2 2026, buying an estimated $1.39K and bringing the position to 1,160 shares worth $3.25K. The position accounts for ﹤0.01% of the portfolio, ranked #4020.

IFP Advisors first reported a position in ANIX in Q2 2017 and has held it in 8 quarters since. 62 funds tracked by Wall St. Rank hold ANIX as of Q2 2026.

  • IFP Advisors held 1,160 shares of Anixa Biosciences worth $3.25K as of Q2 2026.
  • IFP Advisors bought 500 Anixa Biosciences shares in Q2 2026, an estimated $1.39K.
  • Anixa Biosciences made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4020 holding.
  • IFP Advisors first reported a position in Anixa Biosciences in Q2 2017 and has held it in 8 quarters since.
  • 62 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.